Clinical trial registration, sponsored by Joshua Woolley, MD, PhD, registered 21 Jun 2021.
Phase 2 · completed · n = 12
Tags: Registry, Psilocybin, Depression, Anxiety, Neurological.
New registrations include psilocybin for methamphetamine use disorder, borderline personality disorder, nicotine craving and premenstrual dysphoric disorder, and a National Institute on Aging trial pairing psilocybin with cognitive training. Results were posted for psilocybin in depression and anxiety in Parkinson's disease.
How much weight it carries: Registrations show what is being attempted, not what was found. (Registry, Plans, not results)
results posted for psilocybin therapy in depression and anxiety in Parkinson's disease, run by Joshua Woolley
How much weight it carries: Trial registry movements: what is being attempted, not what was found. (Registry, Plans, not results)